Geode Capital Management’s Eikon Therapeutics EIKN Stock Holding History
Bought
Maintained
Sold
Other funds holding EIKN
Geode Capital Management's EIKN Position: Q3 2026 in Review
Geode Capital Management increased its Eikon Therapeutics (EIKN) stake by 35% in Q3 2026, buying an estimated $1.99M and bringing the position to 754,499 shares worth $6.07M. The position accounts for ﹤0.01% of the portfolio, ranked #2742.
Geode Capital Management first reported a position in EIKN in Q1 2026 and has held it in 3 quarters since. The position peaked at $7.27M in Q2 2026. 98 funds tracked by Wall St. Rank hold EIKN as of Q3 2026.
- Geode Capital Management held 754,499 shares of Eikon Therapeutics worth $6.07M as of Q3 2026.
- Geode Capital Management bought 197,544 Eikon Therapeutics shares in Q3 2026, an estimated $1.99M.
- Eikon Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #2742 holding.
- Geode Capital Management first reported a position in Eikon Therapeutics in Q1 2026 and has held it in 3 quarters since.
- Geode Capital Management's Eikon Therapeutics position peaked at $7.27M in Q2 2026.
- 98 funds tracked by Wall St. Rank held Eikon Therapeutics as of Q3 2026.
Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.